Wednesday, May 7, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

940 POSTS 0 COMMENTS
Athersys, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Adding Organicell (BPSR) $0.02 to the Watch List.

Editor / Curator -
America BriVision, Biotech Stock Review
Incubator

Adding American BriVision (ABVC) $2.00 to Watch List.

Editor / Curator -
Biotech News

Athersys (ATHX) Overview and Due Diligence links (Reddit)

Editor / Curator -
Internet Stock Review
Stand Down.

Immunomedics (IMMU) up 100% Today or $2 Billion in Value &...

Editor / Curator -
Biotech Stock Review, Novellus, Citius
Biotech News

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS)...

Editor / Curator -
Superbug News - CoronaVirus Watch List

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and...

Editor / Curator -
OMNIQ
Cybersecurity

OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.

Editor / Curator -
All News

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Editor / Curator -
1...707172...94Page 71 of 94

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

All News Editor / Curator -
Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.